IOVA — IOVANCE BIOTHERAPEUTICS INC

Ownership history in Voss Capital, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Voss Capital, LP reported a position in IOVANCE BIOTHERAPEUTICS INC (IOVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.73% (2020 Q2)
Avg. % of fund
0.3%
First filed
2020 Q2
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 672,570 — 0% 0.08% $1.2M $2.17
2025 Q2 ADDED 672,570 +632,570 +1581.4% 0.08% $1.2M $1.72
2020 Q2 INITIATED 40,000 — — 0.73% $1.1M $27.45
% of Fund (quarterly)    IOVA price (monthly, adj. close)

Other funds also holding IOVA

As of 2025 Q4 — sorted by position size

MHR FUND MANAGEMENT LLC 3Y 7Y 6.81% B Group, Inc. 3.02% Palo Alto Investors LP 3Y 7Y 2.7% Orion Investment Co 1.54% Invenomic Capital Management LP 3Y 1.52% CM Management, LLC 3Y 0.92% Parametrica Management Ltd 3Y 7Y 0.82% Long Focus Capital Management, LLC 3Y 0.62% Rhenman & Partners Asset Management AB 3Y 7Y 0.41% Mirador Capital Partners LP 3Y 7Y 0.39%
← Back to Voss Capital, LP Holdings